Literature DB >> 23532498

Letter to the editor re: positron emission tomography with [(18)F]-3'-deoxy-3'fluorothymidine (FLT) as a predictor of outcome in patients with locally advanced resectable rectal cancer: a pilot study.

A Chalkidou1, G Mikhaeel, M J O'Doherty, P K Marsden.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23532498     DOI： 10.1007/s11307-013-0628-9

Source DB:  PubMed          Journal:  Mol Imaging Biol        ISSN： 1536-1632            Impact factor:   3.488


× No keyword cloud information.
  8 in total

1.  Positron emission tomography with [(18)F]-3'-deoxy-3'fluorothymidine (FLT) as a predictor of outcome in patients with locally advanced resectable rectal cancer: a pilot study.

Authors:  Farrokh Dehdashti; Perry W Grigsby; Robert J Myerson; Ilke Nalbantoglu; Changqing Ma; Barry A Siegel
Journal:  Mol Imaging Biol       Date:  2013-02       Impact factor: 3.488

2.  Accurate prediction of pathological rectal tumor response after two weeks of preoperative radiochemotherapy using (18)F-fluorodeoxyglucose-positron emission tomography-computed tomography imaging.

Authors:  Marco H M Janssen; Michel C Ollers; Robert G Riedl; Jørgen van den Bogaard; Jeroen Buijsen; Ruud G P M van Stiphout; Hugo J W L Aerts; Philippe Lambin; Guido Lammering
Journal:  Int J Radiat Oncol Biol Phys       Date:  2009-07-29       Impact factor: 7.038

3.  NCCN Clinical Practice Guidelines in Oncology: rectal cancer.

Authors:  Paul F Engstrom; Juan Pablo Arnoletti; Al B Benson; Yi-Jen Chen; Michael A Choti; Harry S Cooper; Anne Covey; Raza A Dilawari; Dayna S Early; Peter C Enzinger; Marwan G Fakih; James Fleshman; Charles Fuchs; Jean L Grem; Krystyna Kiel; James A Knol; Lucille A Leong; Edward Lin; Mary F Mulcahy; Sujata Rao; David P Ryan; Leonard Saltz; David Shibata; John M Skibber; Constantinos Sofocleous; James Thomas; Alan P Venook; Christopher Willett
Journal:  J Natl Compr Canc Netw       Date:  2009-09       Impact factor: 11.908

4.  The relationship of pathologic tumor regression grade (TRG) and outcomes after preoperative therapy in rectal cancer.

Authors:  Fabio Maria Vecchio; Vincenzo Valentini; Bruce D Minsky; Gilbert D A Padula; Ennapadam S Venkatraman; Mario Balducci; Francesco Miccichè; Riccardo Ricci; Alessio Giuseppe Morganti; Maria Antonietta Gambacorta; Francesca Maurizi; Claudio Coco
Journal:  Int J Radiat Oncol Biol Phys       Date:  2005-07-01       Impact factor: 7.038

5.  The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM.

Authors:  Stephen B Edge; Carolyn C Compton
Journal:  Ann Surg Oncol       Date:  2010-06       Impact factor: 5.344

Review 6.  Correlation between Ki-67 immunohistochemistry and 18F-fluorothymidine uptake in patients with cancer: A systematic review and meta-analysis.

Authors:  A Chalkidou; D B Landau; E W Odell; V R Cornelius; M J O'Doherty; P K Marsden
Journal:  Eur J Cancer       Date:  2012-05-31       Impact factor: 9.162

7.  Multidisciplinary Rectal Cancer Management: 2nd European Rectal Cancer Consensus Conference (EURECA-CC2).

Authors:  Vincenzo Valentini; Cynthia Aristei; Bengt Glimelius; Bruce D Minsky; Regina Beets-Tan; Jose M Borras; Karin Haustermans; Philippe Maingon; Jens Overgaard; Lars Pahlman; Phil Quirke; Hans-Joachim Schmoll; David Sebag-Montefiore; Irving Taylor; Eric Van Cutsem; Cornelius Van de Velde; Numa Cellini; Paolo Latini
Journal:  Radiother Oncol       Date:  2009-08       Impact factor: 6.280

8.  Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma. Clinicopathologic correlations.

Authors:  A M Mandard; F Dalibard; J C Mandard; J Marnay; M Henry-Amar; J F Petiot; A Roussel; J H Jacob; P Segol; G Samama
Journal:  Cancer       Date:  1994-06-01       Impact factor: 6.860
  8 in total
  1 in total

1.  Response to the letter to the editor regarding the manuscript entitled "positron emission tomography with [(18)F]-3'-deoxy-3'fluorothymidine (FLT) as a predictor of outcome in patients with locally advanced resectable rectal cancer: a pilot study".

Authors:  Farrokh Dehdashti; Perry W Grigsby; Barry A Siegel
Journal:  Mol Imaging Biol       Date:  2013-12       Impact factor: 3.488
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.